FDA finds little handwashing, dirty equipment at McDonald's supplier linked to E. coli outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
FDA finds little handwashing, dirty equipment at McDonald's supplier linked to outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
Demystifying AI
The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...
Which Foods Are Actually 'Healthy'? The FDA Will Now Tell You
The FDA is putting guardrails around how and when food companies can use the term "healthy" in food packaging to help consumers make more informed decisions about what they consume. Here's what you ...
Report: FDA lags on food safety inspections due to COVID-19 backlog
Facing personnel shortages and pandemic disruptions, the U.S. Food and Drug Administration has failed to meet requirements ...
Drug to treat rare pediatric disease accepted for FDA review
A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.
STAT22h
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
Healio19h
FDA grants priority review to nipocalimab for myasthenia gravis
The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...
STAT20h
In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
FiercePharma23h
FDA cancels adcomm in 'positive' sign for Exelixis’ Cabometyx bid in neuroendocrine tumors: analyst
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
FiercePharma22h
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
BioPharma Dive20h
Patrizia Cavazzoni, key FDA official, to leave agency
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...